OTC: TRSSF - TerrAscend Corp.

Yield per half year: 0%
Dividend yield: 0.00%
Sector: Healthcare

TerrAscend Corp.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
10/10
7.12 31.48 -77.38% -9.87 -172.15%
P/S 1.18 3.24 -63.46%
P/BV 0.9135 3.36 -72.82%
P/FCF -7.16 21.26 -133.7%
Ev/Ebitda -1.87 9.95 -118.8%
Ev/S 1.86 1.89 -1.62%
Ev/FCF -6.79 19.96 -134%
E/P -0.6679 1.47 -145.49%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-99.47 24.35 -508.57% -112.43 -11.53%
ROE -119.97 13.19 -1009.52%
ROA -50.7 6.14 -926.05%
ROIC 2.83 15.56 -81.81%
ROS -131.32 12.56 -1145.59%
ROCE -58.97 14.36 -510.76%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-1.02 6.21 -116.37% -0.2878 +253.43%
Nеt Debt/Ebitda -0.6815 -5.72 -88.1%
Debt/Ratio 0.3573 0.2122 68.41%
Debt/Equity 1.16 12.49 -90.7%
Debt/Net Income -0.7704 15.05 -105.12%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.76 -100% 0 0%
Number of years of dividend growth 0 1.21 -100%
DSI 0 0.7783 -100%
Average dividend growth 0 -269.81 -100%
Average percentage for 5 years 0 2.8 -100%
Average percentage for payments 0 246.79 -100%
Difference from average difference in sector -1.76

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
289.4 140.59 105.85%
Growth impulse Ebitda in 5 years 17.95 107.17 -83.25%
Growth impulse Net Income in 5 years 102.86 123.16 -16.48%
Growth impulse FCF in 5 years -62.56 93.68 -166.78%
Growth impulse EPS in 5 years -26.59 229.02 -111.61%
IP Score
4.27/10

Similar companies

Curaleaf Holdings, Inc.

Trulieve Cannabis Corp.

Teligent, Inc.

Eisai Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription